发明授权
US08134001B2 Spiroindolinone derivatives 失效
螺吲哚啉酮衍生物

Spiroindolinone derivatives
摘要:
There are provided compounds of the formula and pharmaceutically acceptable salts and esters thereof wherein W, V, X, Y, A, R and R′ are as described herein. The compounds are useful as anticancer agents.
公开/授权文献
信息查询
0/0